Reagents
The restriction enzymes, T4 DNA ligase, thermophilic polymerases, and other PCR reagents were purchased from New England Biolabs (Beverly, MA). The oligonucleotides used were synthesized by Bioneer (Chungwon, Korea). All other molecular biology reagents were purchased from commercial sources and were of analytical grade.
Plasmids
For the periplasmic and cytoplasmic expression of proteins in fusion with the maltose binding protein (MBP), cloning plasmids were constructed from pMALp2x, and expression plasmids were made from pMALc2x. The TEM-1 β-lactamase gene encoded in pMAL vectors was replaced with the aminoglycoside 3'-phosphotransferase (kanamycin-resistance) gene from pACYC177 using PCR with the primer pairs Nmal/Cmal and Nkan/Ckan. This resulted in the plasmids p2KP and p2KC (6.1-kb). Substitution of the antibiotics-resistance gene was verified by sequencing of the entire vector, phenotypic resistance on kanamycin, and sensitivity on ampicillin.
Oligonucleotides
The following ologinucleotides in this work were used: Nmal, 
Construction of a library by the SIAFE process
The gene encoding human glyoxalase II (GlyII, 260 amino acids) was subcloned from plasmid pKHGII (1 transformants was screened on selective agar plates containing 0.05 mM isopropyl-β-Dthiogalactoside (IPTG), 0.2 mM ZnCl 2 , 50 µg/ml kanamycin, and 0.2 µg/ml cefotaxime.
After incubation at 30 o C for 48 ~ 56 h, colonies were picked and transferred onto the same selective plates followed by incubation for 48 h. In order to isolate true positives, plasmids of primary clones were isolated and transferred into fresh E. coli XL1-Blue, and the resulting clones were checked for resistance against cefotaxime on the same selective agar plates
DNA shuffling
Shuffling of the pool of genes from each round of directed evolution was carried out using 50 ~ 100 bp fragments, and reassembled by PCR as described (2) . The resulting DNA fragments were cloned into p2KP, and introduced into E. coli XL1-Blue by using electroporation. A library of 2.5 ~ 7.1 x 10 7 transformants was screened on selective LB agar plates as described above with increasing concentrations of cefotaxime (0.2 ~ 4.5 µg/ml).
Colonies grown at a given selection pressure were picked and confirmed by retransformation into a fresh host. A mixture of plasmids from confirmed positive clones was prepared and used for the next round of DNA shuffling. At the fourth round, to increase the diversity of the library, additional mutagenic PCR was conducted with error rates of 1 ~ 3%. The nucleotide sequence of the finally selected evMBL8 was determined (GenBank accession number; DQ307739).
Expression of wild type and evolved enzymes
Wild type IMP-1 (3) and GlyII, and evMBL mutants were amplified by PCR and cloned into a p2KC vector for cytoplasmic expression. E. coli XL1-Blue cells containing recombinant plasmids were grown at 37 o C in LB broth containing 50 µg/ml kanamycin.
When the optical density reached 0.6 at 600nm, 0.1 mM IPTG and 0.2 mM ZnCl 2 were added to the culture medium followed by further growth at 30 o C for 6 ~ 9 h. Cells were harvested, resuspended in lysis buffer (50 mM Hepes buffer pH 7.4, 200 mM NaCl), and subjected to sonication. The lysate was centrifuged at 10,000 X g, and the supernatant was applied to an amylose resin column. Further purification was performed according to the manufacturer's instruction. Protein concentration was determined by the Bradford method.
Analysis of cell growth in liquid media
Cells from overnight cultures were diluted into 5ml LB broth containing 0.05 mM IPTG, 0.2 mM ZnCl 2 , 50 µg/ml kanamycin, and various concentrations of cefotaxime (0.02 ~ 2.0 µg/ml). Cells were grown at 30 o C in the test tube from a starting optical density of 0.04 at 600nm. Optical density was checked every 2 h.
Assay of enzyme activity
β-Lactamase activity was assayed by monitoring the decrease in absorbance at 260nm using a UV/Vis spectrophotometer (4). The reaction mixture contained 1 ~ 2 µM wild type or 1 ~ 2 mM evolved enzymes, 50 mM Hepes (pH 7.4), and 0.02 ~ 2.0 mM cefotaxime in a reaction volume of 1ml. β-Lactamase activity was also measured using highperformance liquid chromatography (HPLC) equipped with a C 18 analytical column at a flow rate of 1mL/min. The solvent used was 10% acetonitrile/0.01% TFA, and the elution was monitored at 260nm. To determine the kinetic parameters, the initial velocity at each substrate concentration (0.02 ~ 0.2 mM for wild type, and 0.2 ~ 2.0 mM for evolved mutants) was measured, and (k cat ) app and (K m ) app values were calculated from the reciprocal plot of the Michaelis-Menten equation.
Analysis of metal content
Metal content of purified wild type and evolved enzymes was measured with a Varian inductively coupled plasma spectrometer (ICP) with atomic emission spectroscopy detection as described elsewhere (5)
Molecular modeling of evMBL8
A molecular model of evMBL8 was constructed using CcrA (PDB entry: 1A7T) and GlyII (PDB entry: 1QH5) as templates. These were selected from a profile-based search using sequence homology. Comparative modeling was performed by using the protein structure modeling program, NanoModel (Nanormics Inc.) (6) . The modeling procedure is as follows. The first step was to construct the model of evMBL8 through the replacement of the corresponding residues in sequence structure alignment with the template.
Insertion/deletion parts in the alignment were modeled using similar loop fragments from Protein Data Bank. As the next step, the side chains of conserved residues were fixed and those of non-conserved residues were adjusted by using a rotamer library. Finally, the structures were refined by an energy-minimized algorithm. The steepest descents for 300 steps and conjugate gradients for 2000 steps were used, with a distance-dependent dielectric constant (4*r). All of the molecular mechanic calculations were carried out using the Discover 2.98 program (Accelrys Inc.), with an AMBER forcefield, and using nonbonded cut off of 10 Å, running on a Silicon Graphics O2 workstation (Silicon Graphics, Mountain View, California, USA). The coordinate of the model was deposited in the protein data bank (PDB entry: 2F50). Autodock 3.0.3 was used to predict the evMBL8-cefotaxime complex structure as previously described (7).
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Investigation of possible contamination by wild type IMP-1 in the bacterial population carrying evMBL8
To confirm that the observed β-lactamase activity of evMBL8 is genuine, and not due to contamination of IMP-1, the following control experiments were conducted. First, we picked five distinct single colonies expressing evMBL8 and IMP-1, respectively, from freshly transformed plates and determined their resistance against antibiotics (0, 1, 2, and 20 µg/mL cefotaxime, and 50µg/mL ampicillin) simply plating around 10 5 cfu per plate. In case of cells expressing wild-type IMP-1, we observed about 10 5 cfu per plate containing high concentrations of antibiotics (20µg/mL of cefotaxime and 50 µg/mL of ampicillin). However, cells carrying evMBL8 gave rise to the same number of colonies as IMP-1 only at low concentrations of cefotaxime (~10 5 cfu on 1 and 2 µg/mL of cefotaxime), and no colonies were found at high concentration of cefotaxime (20µg/mL) and ampicillin (50 µg/mL). Based on this result, the possibility of contamination by IMP-1 in the bacterial population carrying evMBL8 was ruled out.
Mutagenesis study of evMBL8
We conducted side-directed mutagenesis of the evolved mutant evMBL8 to investigate the role of predicted metal ligands (H66, H68, and H131 for metal; D70, C155, and H194 for metal 2) in catalytic reaction. All residues were mutated to Ala (one at a time)
by using overlapping PCR with following mutagenic oligonucleotide primer sets (66N/66C for H66A, 68N/68C for H68A, 70N/70C for D70A, 131N/131C for H131A, 155AN/155C for C155A, and NT1/194C for H194A). When the resulting mutants were checked for their activities, it was revealed that all six individual mutants lost catalytic activities and gave no growth on antibiotic selective plate with cefotaxime concentration as low as 0.2 µg/mL. We also carried out two additional mutations (C71H and C155D) in an attempt to restore GlyIIlike metal coordination (H59 and D134) in evMBL8 by using two sets of oligonucleotide primers (71N/71C for C71H and 155DN/155C for C155D). The two resultant mutants were found to lose catalytic activities, and did not show antibiotic resistance against cefotaxime.
Thus, it is reasonable that evMBL8 has evolved to have β-lactamase activity, retaining the designed metal coordination of IMP-1 essential for catalysis.
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Zn stab The active site structure of evMBL8 (pink ribbon) aligned with that of GlyII (green ribbon).
Residues participating in substrate binding are shown in blue, and ligands for metal coordination are in red. Cefotaxime is shown in yellow. 
